Michael Davidson

Michael Davidson

DirectoratNewAmsterdam Pharma Co· In proxies 2023–2025

Pay in FY2025+111% from the year before · NewAmsterdam Pharma Co stock +36.5% the same year

Michael Davidson was paid $13.6M in FY2025 (Dec), up 111%. NewAmsterdam Pharma Co stock rose 36.5% that year.

Pay$100 in the stock at the end of FY23 → $314
Pay is from the Summary Compensation Table of each NewAmsterdam Pharma Co proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BioAge LabsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. NewAmsterdam Pharma CoPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role +83%
  3. Tenax Therapeutics, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  4. AbcentraPublic company
    • Director? – PresentNo stock prices for these years
  5. BioAge Labs, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. NanoPhoria BiosciencePublic company
    • Director? – PresentNo stock prices for these years
  7. SonoThera, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Silence TherapeuticsPublic company · 3 yr
    • Director2022 – 2025 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • BioAge LabsDirector · 1 yr on the boardIndependentCompensation (Chair), Nominating and Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?